{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:52:14Z","timestamp":1773888734740,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["BOF DOCPRO 31552"],"award-info":[{"award-number":["BOF DOCPRO 31552"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0824-3","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T08:09:52Z","timestamp":1502957392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection"],"prefix":"10.1186","volume":"14","author":[{"given":"Winke","family":"Van der Gucht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"De Schryver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Heykers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"824_CR1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","author":"AR Falsey","year":"2005","unstructured":"Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749\u201359.","journal-title":"N Engl J Med"},{"key":"824_CR2","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JVI.01625-07","volume":"82","author":"PL Collins","year":"2008","unstructured":"Collins PL, Graham BS. Viral and host factors in human respiratory Syncytial virus pathogenesis. J Virol. 2008;82:2040\u201355.","journal-title":"J Virol"},{"key":"824_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","volume":"45","author":"AT Borchers","year":"2013","unstructured":"Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol. 2013;45:331\u201379.","journal-title":"Clin Rev Allergy Immunol"},{"key":"824_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060416","volume":"8","author":"L Houspie","year":"2013","unstructured":"Houspie L, Lemey P, Keyaerts E, Reijmen E, Vergote V, Vankeerberghen A, et al. Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes. PLoS One. 2013;8:e60416.","journal-title":"PLoS One"},{"key":"824_CR5","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/JVI.76.11.5654-5666.2002","volume":"76","author":"L Zhang","year":"2002","unstructured":"Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory Syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious Cytopathology. J Virol. 2002;76:5654\u201366.","journal-title":"J Virol"},{"key":"824_CR6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s15010-013-0557-1","volume":"42","author":"TF Leung","year":"2014","unstructured":"Leung TF, Lam DSY, Miu TY, Hon KL, Chau CSK, Ku SW, et al. Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children. Infection. 2014;42:343\u201350.","journal-title":"Infection"},{"key":"824_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coviro.2017.03.012","volume":"23","author":"BS Graham","year":"2017","unstructured":"Graham BS. Vaccine development for respiratory syncytial virus. Curr Opin Virol Elsevier B V. 2017;23:107\u201312.","journal-title":"Curr Opin Virol Elsevier B V"},{"key":"824_CR8","first-page":"S40","volume":"22","author":"HC Meissner","year":"2003","unstructured":"Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr. Infect Dis J. 2003;22:S40\u20134. discussion S44\u20135","journal-title":"Infect Dis J"},{"key":"824_CR9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","volume":"375","author":"H Nair","year":"2010","unstructured":"Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet Elsevier Ltd. 2010;375:1545\u201355.","journal-title":"Lancet Elsevier Ltd"},{"key":"824_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2015.04.005","volume":"35","author":"BS Graham","year":"2015","unstructured":"Graham BS, Modjarrad K, McLellan JS. Novel antigens for RSV vaccines. Curr Opin Immunol. 2015;35:30\u20138.","journal-title":"Curr Opin Immunol"},{"key":"824_CR11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","volume":"176","author":"S Johnson","year":"1997","unstructured":"Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis. 1997;176:1215\u201324.","journal-title":"J Infect Dis"},{"key":"824_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/JVI.01226-06","volume":"81","author":"RL Crim","year":"2007","unstructured":"Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA. Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. J Virol. 2007;81:261\u201371.","journal-title":"J Virol"},{"key":"824_CR13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1440-1797.2008.01012.x","volume":"13","author":"Y Guo","year":"2008","unstructured":"Guo Y, Wang Z, Dong L, Wu J, Zhai S, Liu D. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection. Nephrology. 2008;13:545\u201353.","journal-title":"Nephrology"},{"key":"824_CR14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/v5030873","volume":"5","author":"P Mastrangelo","year":"2013","unstructured":"Mastrangelo P, Hegele R. RSV fusion: time for a new model. Viruses. 2013;5:873\u201385.","journal-title":"Viruses"},{"key":"824_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003309","volume":"9","author":"MA Krzyzaniak","year":"2013","unstructured":"Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 2013;9:e1003309.","journal-title":"PLoS Pathog"},{"key":"824_CR16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1099\/0022-1317-83-3-611","volume":"83","author":"G Brown","year":"2002","unstructured":"Brown G, Aitken J, Rixon HWM, Sugrue RJ. Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J. Gen. Virol. 2002;83:611\u201321.","journal-title":"J. Gen. Virol."},{"key":"824_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.pone.0056762","volume":"8","author":"R Geller","year":"2013","unstructured":"Geller R, Andino R, Frydman J. Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory Syncytial virus. PLoS One. 2013;8:13\u201320.","journal-title":"PLoS One"},{"key":"824_CR18","doi-asserted-by":"crossref","first-page":"e0144648","DOI":"10.1371\/journal.pone.0144648","volume":"10","author":"YM Ohol","year":"2015","unstructured":"Ohol YM, Wang Z, Kemble G, Duke G. Direct inhibition of cellular fatty acid Synthase impairs replication of respiratory Syncytial virus and other respiratory viruses. PLoS One. 2015;10:e0144648.","journal-title":"PLoS One"},{"key":"824_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.237.45","volume":"237","author":"H Nishimura","year":"2015","unstructured":"Nishimura H, Yamaya M. A synthetic serine protease inhibitor, Nafamostat Mesilate, is a drug potentially applicable to the treatment of Ebola virus disease. Tohoku J Exp Med. 2015;237:45\u201350.","journal-title":"Tohoku J Exp Med"},{"key":"824_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0134707","volume":"10","author":"PA Gallay","year":"2015","unstructured":"Gallay PA, Bobardt MD, Chatterji U, Trepanier DJ, Ure D, Ordonez C, et al. The novel cyclophilin inhibitor CPI-431-32 concurrently blocks HCV and HIV-1 infections via a similar mechanism of action. PLoS One. 2015;10:1\u201318.","journal-title":"PLoS One"},{"key":"824_CR21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pupt.2015.07.001","volume":"33","author":"M Yamaya","year":"2015","unstructured":"Yamaya M, Shimotai Y, Hatachi Y, Lusamba Kalonji N, Tando Y, Kitajima Y, et al. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. Pulm Pharmacol Ther Elsevier Ltd. 2015;33:66\u201374.","journal-title":"Pulm Pharmacol Ther Elsevier Ltd"},{"key":"824_CR22","doi-asserted-by":"crossref","first-page":"12552","DOI":"10.1128\/JVI.01890-13","volume":"87","author":"K Shirato","year":"2013","unstructured":"Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013;87:12552\u201361.","journal-title":"J Virol"},{"key":"824_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-1702(00)00149-0","volume":"68","author":"G Bolt","year":"2000","unstructured":"Bolt G, Pedersen L\u00d8, Birkeslund HH. Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. Virus Res. 2000;68:25\u201333.","journal-title":"Virus Res"},{"issue":"Pt 9","key":"824_CR24","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1099\/0022-1317-66-9-1983","volume":"66","author":"BF Fernie","year":"1985","unstructured":"Fernie BF, Dapolito G, Cote PJ, Gerin JL. Kinetics of synthesis of respiratory syncytial virus glycoproteins. J. Gen. Virol. 1985;66(Pt 9):1983\u201390.","journal-title":"J. Gen. Virol."},{"key":"824_CR25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1099\/0022-1317-66-6-1241","volume":"66","author":"C Gruber","year":"1985","unstructured":"Gruber C, Levine S. Respiratory syncytial virus polypeptides. V. The kinetics of glycoprotein synthesis. J Gen Virol. 1985;66:1241\u20137.","journal-title":"J Gen Virol"},{"issue":"Pt 12","key":"824_CR26","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1099\/0022-1317-72-12-3095","volume":"72","author":"PL Collins","year":"1991","unstructured":"Collins PL, Mottet G. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol. 1991;72(Pt 12):3095\u2013101.","journal-title":"J Gen Virol"},{"key":"824_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.2002.1497","volume":"298","author":"M Bego\u00f1a Ruiz-Arg\u00fcello","year":"2002","unstructured":"Bego\u00f1a Ruiz-Arg\u00fcello M, Gonz\u00e1lez-Reyes L, Calder LJ, Palomo C. Mart\u0131\u0301n D, Sa\u0131\u0301z MJ, et al. effect of Proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory Syncytial virus and fate of the intervening segment. Virology. 2002;298:317\u201326.","journal-title":"Virology"},{"key":"824_CR28","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1073\/pnas.151098198","volume":"98","author":"L Gonzalez-Reyes","year":"2001","unstructured":"Gonzalez-Reyes L, Ruiz-Arguello MB, Garcia-Barreno B, Calder L, Lopez JA, Albar JP, et al. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A. 2001;98:9859\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"824_CR29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1128\/JVI.02351-15","volume":"90","author":"J Corry","year":"2015","unstructured":"Corry J, Johnson SM, Cornwell J, Peeples ME. Prevention of respiratory Syncytial virus attachment protein cleavage in Vero cells rescues infectivity of progeny Virions for primary human airway cultures. J Virol. 2015;90:1311\u201320.","journal-title":"J Virol"},{"key":"824_CR30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.15252\/emmm.201404005","volume":"6","author":"B Schepens","year":"2014","unstructured":"Schepens B, Sedeyn K, Vande Ginste L, De Baets S, Schotsaert M, Roose K, et al. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein. EMBO Mol Med. 2014;6:1436\u201354.","journal-title":"EMBO Mol Med"},{"key":"824_CR31","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/AAC.36.7.1432","volume":"36","author":"M Hosoya","year":"1992","unstructured":"Hosoya M, Matsuyama S, Baba M, Suzuki H, Shigeta S. Effects of protease inhibitors on replication of various myxoviruses. Antimicrob Agents Chemother. 1992;36:1432\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"824_CR32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuro.2007.08.008","volume":"28","author":"V Anantharam","year":"2007","unstructured":"Anantharam V, Kaul S, Song C, Kanthasamy A, Kanthasamy AG. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology. 2007;28:988\u201397.","journal-title":"Neurotoxicology"},{"key":"824_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00224-1","volume":"374","author":"P Megyeri","year":"1999","unstructured":"Megyeri P, N\u00e9meth L, Pabst KM, Pabst MJ, Deli MA, \u00c1brah\u00e1m CS. 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-??-induced blood-brain barrier opening. Eur J Pharmacol. 1999;374:207\u201311.","journal-title":"Eur J Pharmacol"},{"key":"824_CR34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s10753-014-9976-0","volume":"38","author":"S Saw","year":"2015","unstructured":"Saw S, Arora N. Protease inhibitor reduces airway response and underlying inflammation in cockroach allergen-induced Murine model. Inflammation. 2015;38:672\u201382.","journal-title":"Inflammation"},{"key":"824_CR35","doi-asserted-by":"crossref","first-page":"e41107","DOI":"10.1371\/journal.pone.0041107","volume":"7","author":"S Saw","year":"2012","unstructured":"Saw S, Kale SL, Arora N. Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease. PLoS One. 2012;7:e41107.","journal-title":"PLoS One"},{"key":"824_CR36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/modpathol.3800725","volume":"20","author":"JE Johnson","year":"2007","unstructured":"Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 2007;20:108\u201319.","journal-title":"Mod. Pathol"},{"key":"824_CR37","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/INF.0b013e318168b706","volume":"27","author":"TP Welliver","year":"2008","unstructured":"Welliver TP, Reed JL, Welliver RC Sr. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J. 2008;27:S92\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"824_CR38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12016-007-8033-2","volume":"34","author":"RC Welliver","year":"2008","unstructured":"Welliver RC. The immune response to respiratory syncytial virus infection: friend or foe? Clin Rev Allergy Immunol. 2008;34:163\u201373.","journal-title":"Clin Rev Allergy Immunol"},{"key":"824_CR39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1203\/01.PDR.0000112244.72924.26","volume":"55","author":"G Piedimonte","year":"2004","unstructured":"Piedimonte G, Hegele RG, Auais A. Persistent airway inflammation after resolution of respiratory Syncytial virus infection in rats. Pediatr Res. 2004;55:657\u201365.","journal-title":"Pediatr Res"},{"key":"824_CR40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.intimp.2013.01.013","volume":"15","author":"Y Kadota","year":"2013","unstructured":"Kadota Y, Sakai N, Fujikawa R, Aoyama E, Zhong M, Tanaka S, et al. Dextran sulfate-induced degradation of spontaneously apoptotic B cells. Int Immunopharmacol. 2013;15:581\u20137.","journal-title":"Int Immunopharmacol"},{"key":"824_CR41","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00280-008-0825-4","volume":"63","author":"AFS Queiroz","year":"2009","unstructured":"Queiroz AFS, Silva RA, Moura RM, Dreyfuss JL, Paredes-Gamero EJ, Souza ACS, et al. Growth inhibitory activity of a novel lectin from Cliona Varians against K562 human erythroleukemia cells. Cancer Chemother Pharmacol. 2009;63:1023\u201333.","journal-title":"Cancer Chemother Pharmacol"},{"key":"824_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(02)02296-3","volume":"451","author":"T Takashima","year":"2002","unstructured":"Takashima T, Kawada N, Maeda N, Okuyama H, Uyama N, Seki S, et al. Pepstatin a attenuates the inhibitory effect of N-acetyl-L-cysteine on proliferation of hepatic myofibroblasts (stellate cells). Eur J Pharmacol. 2002;451:265\u201370.","journal-title":"Eur J Pharmacol"},{"key":"824_CR43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2249.2006.03089.x","volume":"144","author":"F Sachse","year":"2006","unstructured":"Sachse F, Von Eiff C, Stoll W, Becker K, Rudack C. Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitis. Clin Exp Immunol. 2006;144:534\u201342.","journal-title":"Clin Exp Immunol"},{"key":"824_CR44","first-page":"629","volume":"86","author":"P Megyeri","year":"1995","unstructured":"Megyeri P, Pabst KM, Pabst MJ. Serine protease inhibitors block priming of monocytes for enhanced release of superoxide. Immunology. 1995;86:629\u201335.","journal-title":"Immunology"},{"key":"824_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtcvs.2007.08.076","volume":"135","author":"Y Iwata","year":"2008","unstructured":"Iwata Y, Nicole O, Okamura T, Zurakowski D, Jonas RA. Aprotinin confers neuroprotection by reducing excitotoxic cell death. J Thorac Cardiovasc Surg. 2008;135:573\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"824_CR46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2307\/3283792","volume":"82","author":"JR Forney","year":"1996","unstructured":"Forney JR, Yang S, Du C, Healey MC. Efficacy of serine protease inhibitors against Cryptosporidium Parvum infection in a bovine fallopian tube epithelial cell culture system. J Parasitol. 1996;82:638\u201340.","journal-title":"J Parasitol"},{"key":"824_CR47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jdermsci.2013.08.006","volume":"72","author":"I Hwang","year":"2013","unstructured":"Hwang I, Park JH, Park HS, Choi KA, Seol KC, Oh SI, et al. Neural stem cells inhibit melanin production by activation of Wnt inhibitors. J Dermatol Sci. 2013;72:274\u201383.","journal-title":"J Dermatol Sci"},{"key":"824_CR48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/exnr.2000.7567","volume":"167","author":"VA Movsesyan","year":"2001","unstructured":"Movsesyan VA, Yakovlev AG, Fan L, Faden A. Effect of serine protease inhibitors on posttraumatic brain injury and neuronal apoptosis. Exp Neurol. 2001;167:366\u201375.","journal-title":"Exp Neurol"},{"key":"824_CR49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2004.09.050","volume":"1030","author":"K Ikegami","year":"2004","unstructured":"Ikegami K, Kato S, Koike T. N-alpha-p-tosyl-l-lysine chloromethyl ketone (TLCK) suppresses neuritic degeneration caused by different experimental paradigms including in vitro Wallerian degeneration. Brain Res. 2004;1030:81\u201393.","journal-title":"Brain Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0824-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T08:10:11Z","timestamp":1502957411000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0824-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0824-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"article-number":"157"}}